INTRODUCTIONFor quick diagnosis and/or decision‐making when critically ill patients are considered, the need of fast and accurate laboratory methods for quantification of serum proteins with predictive value is of high importance. Human serum gelsolin (se‐GSN) is a Ca2+‐dependent 93 kDa protein mainly synthesized by skeletal muscle cells and consisting of 6 gelsolin homolog domains. Aside from its actin‐binding capacity, se‐GSN is suggested to be involved in the modulation of inflammatory processes, too. In severe systemic inflammation, as sepsis, se‐GSN levels drop significantly. Gelsolin is part of the so called actin scavenger system and therefore a possible reason for its decrease is the excessive release of filamentous actin into the circulation due to massive cell injury, and—in case of bacterial infections—the appearance of high amounts of bacterial wall lipids as well. Up to now, only a few studies have proven the possible predictive capacity of GSN levels in sepsis, severe burns, traumatic brain injury, but also in autoimmune diseases, chronic kidney disease, and HIV‐1 disease. However, even at present a rapid automated measurement of this actin‐binding protein still remains a challenge. The aim of the present work was to develop and validate a fast immune turbidimetric assay for serum GSN that
Journal of Clinical Laboratory Analysis – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera